Today

Agents

Chat

Arena

Discover

More

App

Perspective Therapeutics Q2 EPS USD -0.22

CATX•2026-08-10

Q2 results

Aug. 10 (Reuters) - Perspective Therapeutics Q2 net income was USD -26.786 million.

Q2 grant revenue:

USD 81 thousand

Q2 net income from continuing operations: USD -26.983 million

Q2 operating income: USD -29.258 million

Related News

James River Q2 net income rises 59% as premiums fall

JRVR•2026-08-10

IAMGOLD closes sale of 35% Bambadji JV stake in Senegal to Fortuna for about $70 million cash

IAG•2026-08-10

Lockheed Martin says NGI Stage 2 rocket motor clears static-fire test in high-vacuum chamber

LMT

•

2026-08-10

Repay Holdings publishes investor presentation on integrated bill payment, customer communications platform

RPAY•2026-08-10

Sable Offshore net loss narrows to $64.22 million in Q2 FY26; revenue turns to $137.13 million

SOC•2026-08-10

Perspective Therapeutics Q2 EPS USD -0.22 - CATX News | Rallies